Periprocedural changes in left ventricular ejection fraction following MitraClip therapy have not yet been fully investigated for their clinical implications and prognostic value.
What are the periprocedural and longitudinal changes in LVEF and their prognostic value in patients with heart failure and mitral regurgitation treated with MitraClip?
Absolute Event Rate: 0% vs 0%
Objective Periprocedural changes in left ventricular ejection fraction (LVEF) and their clinical implications in patients undergoing MitraClip have not yet been fully investigated. This study aimed to evaluate the periprocedural and longitudinal changes in LVEF and their prognostic value in patients with mitral regurgitation (MR) treated with MitraClip.
Minami et al. (Thu,) reported a other. Periprocedural changes in left ventricular ejection fraction following MitraClip therapy have not yet been fully investigated for their clinical implications and prognostic value.